Pharmed has sold Accuscience to Diploma PLC
Ireland and UK-based Accuscience has been sold by Pharmed to Diploma PLC.
Accuscience, based in Naas, Ireland, distributes life sciences and medtech equipment. It is a recognized leader in core market segments of the Irish healthcare sector, including clinical diagnostics, blood tracking, resuscitation and mobile/modular healthcare facilities. Through relationships with over 100 suppliers, it delivers a full continuum of value-add services in both Ireland and Northern Ireland, including to the HSE and the NHS.
Diploma is an international group supplying specialized products and services in the life sciences, seals and controls sectors across the UK, Northern Europe, North America and Australia.
Pharmed is a major healthcare and pharmaceutical services provider in Ireland and the UK offering a variety of tailor-made solutions to distribution, sales and marketing for the purpose of representing manufacturers of beauty, pharmaceutical and OTC products. With established global networks, Pharmed provides an extensive range of services to meet the strategic requirements of its partners.
Oaklins’ team in Ireland provided corporate finance advice to Pharmed in this sell-side transaction as well as overall project management services to management and the board. This was a very competitive process with a number of serious bidders from multiple jurisdictions in Europe.
Talk to the deal team
Related deals
MEDIK Hospital Design Group has been acquired by STERIS
The private shareholders of MEDIK Hospital Design Group have sold their shares to STERIS plc. Together, MEDIK and STERIS will expand their offerings for hospitals and ambulatory surgery centers worldwide. MEDIK’s solutions ideally complement STERIS’ existing portfolio, enabling the combined group to strengthen its position as a leading provider of turnkey room solutions in surgical and IPT environments. The MEDIK management team will actively support the next phase of growth.
Learn morebioXXmed AG has sold Rancoderm GmbH to Rose Investment- und Beteiligungs AG
Rancoderm GmbH has been acquired by Rose Investment- und Beteiligungs AG to secure the funding required for the final development and market approval of its medical device DermaPro. The acquisition will enable Rancoderm to bring DermaPro to market readiness and launch it as a certified medical product for broad distribution.
Learn moreSLT has been acquired by Indutrade
SLT S.r.l. has been acquired by Indutrade AB and will be integrated into the group’s life science business area. The transaction is Indutrade’s fifth acquisition in 2025 and is expected to have a marginally positive impact on the group’s earnings per share.
Learn more